| Valiant Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543998 |
NSE Symbol : VALIANTLAB |
P/E(TTM) : 60.54 |
|
ISIN Demat : INE0JWS01017 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.02 |
|
Book Value(₹) : 58.87 |
Market Cap(₹Cr) : 335.38 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 65.30 | 54.74 | 45.99 | 51.01 | 57.77 | 35.23 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 65.30 | 54.74 | 45.99 | 51.01 | 57.77 | 35.23 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.77 | 0.61 | 0.85 | 0.67 | 0.65 | 0.67 |
| Total Income | 66.08 | 55.35 | 46.83 | 51.68 | 58.42 | 35.89 |
| Total Expenditure | 60.80 | 54.49 | 45.93 | 48.65 | 53.94 | 34.60 |
| PBIDT | 5.27 | 0.86 | 0.91 | 3.03 | 4.48 | 1.29 |
| Interest | 0.02 | 0.03 | 0.14 | 0.07 | 0.05 | 0.06 |
| PBDT | 5.26 | 0.82 | 0.77 | 2.96 | 4.43 | 1.23 |
| Depreciation | 0.52 | 0.72 | 0.51 | 0.51 | 0.51 | 0.51 |
| Tax | 1.05 | 0.00 | 0.03 | 0.58 | 0.06 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.15 | 0.08 | 0.06 | 0.05 | 0.63 | -0.88 |
| Reported Profit After Tax | 3.53 | 0.03 | 0.17 | 1.82 | 3.24 | 1.60 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 3.53 | 0.03 | 0.17 | 1.82 | 3.24 | 1.60 |
| EPS (Unit Curr.) | 0.65 | 0.01 | 0.03 | 0.42 | 0.74 | 0.37 |
| EPS (Adj) (Unit Curr.) | 0.65 | 0.01 | 0.03 | 0.39 | 0.69 | 0.34 |
| Calculated EPS (Unit Curr.) | 0.65 | 0.01 | 0.03 | 0.42 | 0.75 | 0.37 |
| Calculated EPS (Adj) (Unit Curr.) | 0.65 | 0.01 | 0.03 | 0.39 | 0.70 | 0.34 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.60 | 0.02 | 0.12 | 1.67 | 2.98 | 1.47 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.60 | 0.02 | 0.12 | 1.55 | 2.77 | 1.36 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 54.31 | 54.31 | 54.31 | 43.45 | 43.45 | 43.45 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 8.07 | 1.57 | 1.98 | 5.94 | 7.75 | 3.66 |
| PBDTM(%) | 8.06 | 1.50 | 1.67 | 5.80 | 7.67 | 3.49 |
| PATM(%) | 5.41 | 0.05 | 0.37 | 3.57 | 5.61 | 4.54 |
